SwitzerlandEPFL develops implantable brain chip for mood and anxiety disorders
Researchers at EPFL in Switzerland have created 'LogSync,' an implantable brain chip designed to monitor brain communication and deliver electrical stimulation to treat mood and anxiety disorders.
Background
Mental health disorders, including mood and anxiety conditions, affect millions globally. Traditional treatments often involve medication and therapy, but research into advanced neurotechnologies like brain implants is exploring new therapeutic avenues. This field aims to offer more targeted interventions for complex neurological and psychiatric conditions.
Quorum · collective opinions
EPFL develops implantable brain chip for mood and anxiety disorders
First report 2h agoLast update 2h ago1 takes 1
neutral reportingneutralShow 2 posts
started 2h ago•Last update 2h ago
Reporting on the development and funding of the new brain chip technology.
iWitness comments
No comments yet — be the first to weigh in.